UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A model for structured introduction of new drugs. The aim is to offer all patients appropriate treatment

Läkartidningen, 2008-10, Vol.105 (42), p.2917-2922

2008

Volltextzugriff (PDF)

An analysis of cholesterol control and statin use in the losartan intervention for endpoint reduction in hypertension study

Clinical therapeutics, 2003-04, Vol.25 (4), p.1186-1199

2003

Volltextzugriff (PDF)

Rational introduction to new drugs requires both a health care and a community perspective

Läkartidningen, 2009, Vol.106 (1-2), p.52

2009

Volltextzugriff (PDF)

Acute hemodynamic and hormonal effects of lisinopril (MK-521) in congestive heart failure

The American heart journal, 1986-07, Vol.112 (1), p.121-129

1986

Volltextzugriff (PDF)

Targeting the renin-angiotensin system for the reduction of cardiovascular outcomes in hypertension: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers

Expert opinion on emerging drugs, 2005-11, Vol.10 (4), p.729-745

2005

Volltextzugriff (PDF)

A model for structured introduction of new drugs. The aim is to offer all patients appropriate treatment

Läkartidningen, 2008, Vol.105 (42), p.2917

2008

Volltextzugriff (PDF)

Quality assurance of diabetes treatment using an existing electronic patient record system

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2006, Vol.15 (4), p.286

2006

Volltextzugriff (PDF)

486 Subacute elevated N-BNP consistently predicts increased mortality and morbidity following complicated acute myocardial infarction, an OPTIMAAL substudy

European journal of heart failure. Supplements, 2003-06, Vol.2 (Suppl_1), p.97-97

2003

Volltextzugriff (PDF)

556 N-BNP during long term follow-up in patients following complicated AMI, an OPTIMAL substudy

European journal of heart failure. Supplements, 2003-06, Vol.2 (Suppl_1), p.119-119

2003

Volltextzugriff (PDF)

Effects on renal function of treatment with cefoxitin sodium alone or in combination with furosemide

Journal of antimicrobial chemotherapy, 1978-01, Vol.4 (suppl-B), p.85-89

1978

Volltextzugriff (PDF)

Alcohol consumption and cardiovascular risk in hypertensives with left ventricular hypertrophy: the LIFE study: The LIFE Substudy

Journal of human hypertension, 2004, Vol.18 (6), p.381-389

2004

Volltextzugriff (PDF)

Renin-angiotensi in-system blockade modulates the deleterious effects of being overweight/obese in patients following acute myocardial infarction

CIRCULATION, 2004, Vol.110 (17), p.822

2004

Volltextzugriff (PDF)

CARDIOVASCULAR COMPLICATIONS IN RELATION TO THE FRAMINGHAM RISK SCORE AND AGE IN HYPERTENSIVE PATIENTS WITH LVH: THE LIFE STUDY

Journal of hypertension, 2000-06, Vol.18, p.S91

2000

Volltextzugriff (PDF)

Elevated N-brain natriuretic peptide predicts death following high-risk anterior myocardial infarction but not following high-risk non-anterior myocardial infarction: an OPTIMAAL substudy

EUROPEAN HEART JOURNAL, 2003, Vol.24, p.151

2003

Volltextzugriff (PDF)

N-brain natriuretic peptide levels in elderly patients during long-term follow-up following complicated myocardial infarction; an OPTIMAAL substudy

EUROPEAN HEART JOURNAL, 2003, Vol.24, p.451

2003

Volltextzugriff (PDF)

Age-dependent event rate and reduction of coronary risk in hypertensive patients with LVH: The life study

American journal of hypertension, 2000-06, Vol.13 (4), p.S60-S61

2000

Volltextzugriff (PDF)

Pharmacokinetics of intravenous timolol in patients with acute myocardial infarction and in healthy volunteers

European journal of clinical pharmacology, 1982, Vol.23 (1), p.43-47

1982

Volltextzugriff (PDF)

A comparative study of the convulsant effects of strychnos alkaloids

Acta pharmaceutica Suecica, 1970-09, Vol.7 (4), p.329

1970

Volltextzugriff (PDF)

Lowering of blood pressure and predictors of response in patients with left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint

American journal of hypertension, 2000-08, Vol.13 (8), p.899-906

2000

Volltextzugriff (PDF)

E014: One year of antihypertensive treatment in patients with LVH: The life study

American journal of hypertension, 1999-04, Vol.12 (S4), p.142A-142A

1999

Volltextzugriff (PDF)

Characteristics of 9194 patients with left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint Reduction in Hypertension

Hypertension (Dallas, Tex. 1979), 1998-12, Vol.32 (6), p.989-997

1998

Volltextzugriff (PDF)

One year of antihypertensive treatment in patients with LVH: the life study

American journal of hypertension, 1999-04, Vol.12 (4), p.142-142

1999

Volltextzugriff (PDF)

H35 Baseline characteristics of the life (Losartan intervention for endpoint reduction) in hypertension study

American journal of hypertension, 1997-04, Vol.10 (S2), p.85A-85A

1997

Volltextzugriff (PDF)

The pharmacologically active alkaloids of Strychnos icaja Baill: strychnine and a new alkaloid, 4-hydroxystrychnine

Acta pharmaceutica Suecica, 1969-02, Vol.6 (1), p.103

1969

Volltextzugriff (PDF)

Effects on renal function of treatment with cefoxitin alone or in combination with furosemide

Scandinavian journal of infectious diseases. Supplementum, 1978 (13), p.73

1978

Volltextzugriff (PDF)

26 – 50 von 54

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(48)
Mit Volltextzugriff
(46)

Publikationsform

Sprache

Englisch
(52)
Schwedisch
(2)

Erscheinungsjahr

n.n

Thema

Humans
(32)
Life Sciences & Biomedicine
(30)
Science & Technology
(30)
Medicin Och Hälsovetenskap
(26)
Female
(25)
Male
(25)
Middle Aged
(25)
Aged
(24)
Biological And Medical Sciences
(19)
Medical Sciences
(19)
Hypertension - Drug Therapy
(15)
Pharmacology. Drug Treatments
(15)
Atenolol - Therapeutic Use
(14)
Cardiovascular System & Cardiology
(14)
Double-Blind Method
(14)
Aged, 80 And Over
(13)
Antihypertensive Agents - Therapeutic Use
(13)
Losartan - Therapeutic Use
(13)
Hypertension
(12)
Losartan
(12)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

A model for structured introduction of new drugs. The aim is to offer all patients appropriate treatment

An analysis of cholesterol control and statin use in the losartan intervention for endpoint reduction in hypertension study

Rational introduction to new drugs requires both a health care and a community perspective

Acute hemodynamic and hormonal effects of lisinopril (MK-521) in congestive heart failure

Targeting the renin-angiotensin system for the reduction of cardiovascular outcomes in hypertension: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers

A model for structured introduction of new drugs. The aim is to offer all patients appropriate treatment

Quality assurance of diabetes treatment using an existing electronic patient record system

486 Subacute elevated N-BNP consistently predicts increased mortality and morbidity following complicated acute myocardial infarction, an OPTIMAAL substudy

556 N-BNP during long term follow-up in patients following complicated AMI, an OPTIMAL substudy

Effects on renal function of treatment with cefoxitin sodium alone or in combination with furosemide

Alcohol consumption and cardiovascular risk in hypertensives with left ventricular hypertrophy: the LIFE study: The LIFE Substudy

Renin-angiotensi in-system blockade modulates the deleterious effects of being overweight/obese in patients following acute myocardial infarction

CARDIOVASCULAR COMPLICATIONS IN RELATION TO THE FRAMINGHAM RISK SCORE AND AGE IN HYPERTENSIVE PATIENTS WITH LVH: THE LIFE STUDY

Elevated N-brain natriuretic peptide predicts death following high-risk anterior myocardial infarction but not following high-risk non-anterior myocardial infarction: an OPTIMAAL substudy

N-brain natriuretic peptide levels in elderly patients during long-term follow-up following complicated myocardial infarction; an OPTIMAAL substudy

Age-dependent event rate and reduction of coronary risk in hypertensive patients with LVH: The life study

Pharmacokinetics of intravenous timolol in patients with acute myocardial infarction and in healthy volunteers

A comparative study of the convulsant effects of strychnos alkaloids

Lowering of blood pressure and predictors of response in patients with left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint

E014: One year of antihypertensive treatment in patients with LVH: The life study

Characteristics of 9194 patients with left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint Reduction in Hypertension

One year of antihypertensive treatment in patients with LVH: the life study

H35 Baseline characteristics of the life (Losartan intervention for endpoint reduction) in hypertension study

The pharmacologically active alkaloids of Strychnos icaja Baill: strychnine and a new alkaloid, 4-hydroxystrychnine

Effects on renal function of treatment with cefoxitin alone or in combination with furosemide

Suchergebnisse filtern